Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.36 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL126274 | 0.89 | ALDH1A1 (0.47) | ALKBH5FTOALDH1A1L3MBTL1KDM4E | |
| SCHEMBL10092208 | 0.81 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1KDM4EATMGPR3 | |
| SCHEMBL15926248 | 0.81 | TSPO (0.39) | ALDH1A1 | |
| SCHEMBL19660505 | 0.80 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1KDM4EATMGPR3 | |
| SCHEMBL12925600 | 0.80 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1KDM4EATMGPR3 | |
| SCHEMBL17792926 | 0.80 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1KDM4EATMGPR3 | |
| SCHEMBL15959784 | 0.80 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1KDM4EATMTSHR | |
| SCHEMBL19068363 | 0.80 | ALDH1A1 (0.37) | ALDH1A1L3MBTL1KDM4EATMTSHR | |
| SCHEMBL2548411 | 0.79 | GPR3 (0.45) | ALDH1A1L3MBTL1KDM4EATMTNKS2 | |
| SCHEMBL18381843 | 0.78 | GPR3 (0.43) | ALDH1A1L3MBTL1KDM4EATMTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230131934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-27 | — | — | US | disclosed |
| US-20230131934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-04-27 | — | — | US | disclosed |
| EP-3632921-A1 | ANCILLARY LIGANDS FOR ORGANOMETALLIC COMPLEXES | Universal Display Corporation (US) | 2020-04-08 | — | — | EP | disclosed |
| US-10403825-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-09-03 | — | — | US | disclosed |
| US-9698357-B2 | Phenanthroline-based compound and use thereof | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-07-04 | — | — | US | disclosed |
| US-20170077410-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2017-03-16 | — | — | US | disclosed |
| US-20160372679-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-12-22 | — | — | US | disclosed |
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORP. | 2016-07-21 | — | — | US | disclosed |
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2016-07-14 | — | — | US | disclosed |
| US-20160155949-A1 | PHENANTHROLINE-BSAED COMPOUND AND USE THEREOF | LUMINESCENCE TECHNOLOGY CORP. | 2016-06-02 | — | — | US | disclosed |
| US-9190619-B2 | Compound for organic electroluminescence device | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-11-17 | — | — | US | disclosed |
| US-9166177-B2 | Ditriphenylene derivative and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2015-10-20 | — | — | US | disclosed |
| US-20150243903-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150243903-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-08-27 | — | — | US | disclosed |
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LUMINESCENCE TECHNOLOGY CORP (TW) | 2015-07-30 | — | — | US | disclosed |
| US-20140231754-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | Yen, Feng-wen (TW) | 2014-08-21 | — | — | US | disclosed |
| WO-2012170463-A1 | HETEROLEPTIC IRIDIUM CARBENE COMPLEXES AND LIGHT EMITTING DEVICE USING THEM | UNIVERSAL DISPLAY CORPORATION (US) | 2012-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10403825-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, OSBP | ALKBH5 807/4885FTO 300/4885ALDH1A1 2138/4885 |
| US-20150243903-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | ALKBH5 807/4885FTO 300/4885ALDH1A1 2138/4885 |
| US-20160372679-A1 | COMPOUNDS FOR ORGANIC ELECTROLUMINESCENCE DEVICE | CCNE2, CYP3A4, CCNE1 | ALKBH5 1420/4885FTO 1910/4885ALDH1A1 169/4885 |
| US-20150214492-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SLCO4C1, LEF1, SLCO2B1 | ALKBH5 641/4885FTO 747/4885ALDH1A1 2542/4885 |
| US-20230131934-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | ALKBH5 807/4885FTO 300/4885ALDH1A1 2138/4885 |
| US-20160211456-A1 | PHENANTHRO[9,10-b]TETRAPHENYLENE DERIVATIVE AND USE THEREOF | POP1, TERB1, AP2B1 | ALKBH5 1568/4885FTO 1509/4885ALDH1A1 2052/4885 |
| US-20160204345-A1 | DITRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | NR2E1, NR0B1, NR2E3 | ALKBH5 362/4885FTO 1412/4885ALDH1A1 3346/4885 |
| US-20160155949-A1 | PHENANTHROLINE-BSAED COMPOUND AND USE THEREOF | MLX, BPNT1, PAH | ALKBH5 2783/4885FTO 1963/4885ALDH1A1 3368/4885 |
| US-20170077410-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND USE THEREOF | HBS1L, EML4, EBPL | ALKBH5 1126/4885FTO 451/4885ALDH1A1 2065/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.